Elanco/Bayer crosses finish line with FTC clearance
The Federal Trade Commission has conditionally approved Elanco’s $7.6 billion purchase of Bayer’s animal health business, granting the final antitrust clearance the companies needed to close the deal.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10